Nuclear Medicine/Radiopharmaceuticals Market Worth US $7.27 Billion by 2021
According to a new market research report "Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021", published by MarketsandMarkets.
View full press release